STOCK TITAN

CNO Financial (NYSE: CNO) insider plans 23,570-share stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider of CNO, identified as Matthew Zimpfer, has filed a notice of intent to sell 23,570 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of 1,017,413.19. The shares are part of a class with 95,353,512 shares outstanding and are expected to be sold on or about 02/17/2026 on the NYSE.

The shares to be sold were acquired on 02/17/2026 via a stock option exercise from the issuer for cash. Zimpfer also sold 30,970 common shares in a prior transaction on 02/12/2026 for gross proceeds of 1,329,582.36. By signing the notice, the seller represents that he is not aware of any undisclosed material adverse information about the issuer’s operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What insider transaction did CNO disclose in this Form 144 notice?

CNO reported that insider Matthew Zimpfer intends to sell 23,570 common shares on or about 02/17/2026. The sale will be executed through Morgan Stanley Smith Barney LLC on the NYSE, based on an aggregate market value of 1,017,413.19.

How many CNO shares is the insider planning to sell and what is their market value?

The insider plans to sell 23,570 CNO common shares with an aggregate market value of 1,017,413.19. These shares are part of a larger class of 95,353,512 shares outstanding, and the planned sale is scheduled around 02/17/2026 on the NYSE.

How did the CNO insider acquire the 23,570 shares being sold?

The 23,570 CNO common shares to be sold were acquired on 02/17/2026 via a stock option exercise from the issuer. The exercise was paid in cash, and the same number of shares acquired is listed as the amount intended for sale in the notice.

What CNO share sales has the insider made in the past three months?

Within the past three months, the insider sold 30,970 CNO common shares on 02/12/2026. That transaction generated gross proceeds of 1,329,582.36. These earlier sales are reported alongside the planned 23,570-share sale in the same notice.

What representation does the CNO insider make about non-public information?

By signing the notice, the insider represents that he does not know any material adverse information about CNO’s current or prospective operations that has not been publicly disclosed. This statement is a required certification when filing a sale notice of this type.

On which exchange will the CNO insider’s shares be sold and through which broker?

The planned sale of 23,570 CNO common shares is listed for execution on the NYSE. The broker handling the transaction is Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004.